Literature DB >> 19236118

Treating hypertension in older adults: safety considerations.

Wilbert S Aronow1.   

Abstract

This article discusses the efficacy, use and adverse effects of antihypertensive drug therapy in older adults. Numerous double-blind, randomized, placebo-controlled studies have demonstrated that antihypertensive drug therapy reduces cardiovascular events in older adults. All antihypertensive drugs may predispose older patients to the development of symptomatic orthostatic hypotension and postprandial hypotension, and syncope or falls. Adverse effects of diuretics, beta-adrenergic receptor antagonists, ACE inhibitors, angiotensin receptor antagonists, calcium channel antagonists, alpha-adrenergic receptor antagonists, centrally acting drugs and direct vasodilators are discussed. The adverse effects depend on the antihypertensive drugs used, the doses used, the co-morbidities present in older patients taking these drugs and drug-drug interactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19236118     DOI: 10.2165/00002018-200932020-00004

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  65 in total

1.  Incidence of new coronary events in older persons with prior myocardial infarction and systemic hypertension treated with beta blockers, angiotensin-converting enzyme inhibitors, diuretics, calcium antagonists, and alpha blockers.

Authors:  Wilbert S Aronow; Chul Ahn
Journal:  Am J Cardiol       Date:  2002-05-15       Impact factor: 2.778

2.  Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice.

Authors:  J Ness; W S Aronow; C Ahn
Journal:  J Am Geriatr Soc       Date:  2000-03       Impact factor: 5.562

3.  Effect of age and high blood pressure on baroreflex sensitivity in man.

Authors:  B Gribbin; T G Pickering; P Sleight; R Peto
Journal:  Circ Res       Date:  1971-10       Impact factor: 17.367

4.  A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure.

Authors:  U Elkayam; J Amin; A Mehra; J Vasquez; L Weber; S H Rahimtoola
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

Review 5.  Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology.

Authors:  Z H Israili; W D Hall
Journal:  Ann Intern Med       Date:  1992-08-01       Impact factor: 25.391

6.  Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program.

Authors:  L V Franse; M Pahor; M Di Bari; G W Somes; W C Cushman; W B Applegate
Journal:  Hypertension       Date:  2000-05       Impact factor: 10.190

7.  Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group.

Authors:  J N Cohn; S Ziesche; R Smith; I Anand; W B Dunkman; H Loeb; G Cintron; W Boden; L Baruch; P Rochin; L Loss
Journal:  Circulation       Date:  1997-08-05       Impact factor: 29.690

8.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.

Authors:  M Packer; C M O'Connor; J K Ghali; M L Pressler; P E Carson; R N Belkin; A B Miller; G W Neuberg; D Frid; J H Wertheimer; A B Cropp; D L DeMets
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

9.  The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study.

Authors:  J Stokes; W B Kannel; P A Wolf; L A Cupples; R B D'Agostino
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

10.  Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients > or = 62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction > or = 40%.

Authors:  W S Aronow; C Ahn; A D Mercando; S Epstein; I Kronzon
Journal:  Am J Cardiol       Date:  1994-08-01       Impact factor: 2.778

View more
  12 in total

Review 1.  Predicting risk of adverse drug reactions in older adults.

Authors:  Amanda Hanora Lavan; Paul Gallagher
Journal:  Ther Adv Drug Saf       Date:  2016-02

2.  Reducing fall risk while managing hypotension, pain, and poor sleep in an 83-year-old woman.

Authors:  Barbara Farrell; Salima Shamji; Nafisa Ingar
Journal:  Can Fam Physician       Date:  2013-12       Impact factor: 3.275

3.  Reducing pill burden and helping with medication awareness to improve adherence.

Authors:  Barbara Farrell; Véronique French Merkley; Nafisa Ingar
Journal:  Can Pharm J (Ott)       Date:  2013-09

4.  Reducing fall risk while managing pain and insomnia: Addressing polypharmacy in an 81-year-old woman.

Authors:  Barbara Farrell; Salima Shamji; Nafisa Ingar
Journal:  Can Pharm J (Ott)       Date:  2013-11

5.  Identifying and managing drug-related causes of common geriatric symptoms.

Authors:  Barbara Farrell; Anne Monahan; Nafisa Ingar
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

Review 6.  Antipsychotic pharmacotherapy and orthostatic hypotension: identification and management.

Authors:  James J Gugger
Journal:  CNS Drugs       Date:  2011-08       Impact factor: 5.749

Review 7.  Role of systems pharmacology in understanding drug adverse events.

Authors:  Seth I Berger; Ravi Iyengar
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-08-27

Review 8.  Variability in the prescription of cardiovascular medications in older patients: correlates and potential explanations.

Authors:  Cinzia Maraldi; Fabrizia Lattanzio; Graziano Onder; Massimo Gallerani; Silvia Bustacchini; Giuseppe De Tommaso; Stefano Volpato
Journal:  Drugs Aging       Date:  2009-12       Impact factor: 3.923

9.  Genetic influence on exercise-induced changes in physical function among mobility-limited older adults.

Authors:  Thomas W Buford; Fang-Chi Hsu; Tina E Brinkley; Christy S Carter; Timothy S Church; John A Dodson; Bret H Goodpaster; Mary M McDermott; Barbara J Nicklas; Veronica Yank; Julie A Johnson; Marco Pahor
Journal:  Physiol Genomics       Date:  2014-01-14       Impact factor: 3.107

10.  Costs of eprosartan versus diuretics for treatment of hypertension in a geriatric population: an observational, open-label, multicentre study.

Authors:  Joaquin A Alvarez Gregori; Juan F Macías Nuñez; Alfonso Domínguez-Gil
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.